If you are considering minoxidil tablets because a scalp product is inconvenient, ask what a route comparison establishes before changing treatment. Hair changes during GLP-1 treatment also need a diagnosis; a pattern-hair-loss trial cannot identify the cause of your shedding.
Who entered the 24-week comparison?
Chaudhry and colleagues randomized 100 adults aged 18–50 with androgenetic alopecia at one center. Ninety completed 24 weeks and entered the analysis: 46 oral, 44 topical. The completers included 54 men and 36 women. Both groups received a tablet and a topical preparation, one active and one placebo; formulations differed by sex.[1]
At least mild photographic improvement occurred in 67.4% with oral versus 72.7% with topical minoxidil. The oral-minus-topical difference was −5.3 percentage points, with a 95% confidence interval from −22 to +12. The trial was not designed to establish equivalence or non-inferiority. Cardiovascular disease was an exclusion.[1]
Increased face or body hair occurred in 30.4% versus 9.1%, respectively. The authors listed no funding and declared no conflicts. Oral hair-loss use is off-label. Photo ratings do not supply objective hair-density measurements, and a small, short study cannot exclude rare or delayed harm.[1]
Read improvement and satisfaction separately
When discussing a paper, ask which result supports the claim being made. A clinician's photo rating, your satisfaction with the routine and a measured hair count answer different questions. Do not relabel a proportion meeting a rating threshold as the percentage of hair restored.
If your main concern is the practical burden of a scalp product, describe that burden: residue, trouble fitting application into the day, or a symptom that occurs after use. Ask which alternatives fit the diagnosis and your medical history. A percentage from a comparative paper cannot make that decision for you.
Confirm the cause before comparing routes
AAD explains that a dermatologist asks about onset and duration, examines the scalp and other relevant areas, and may investigate suspected disease, deficiency, hormonal causes or infection with testing. More than one cause of hair loss can coexist.[2]
Bring the date shedding started, whether the change was sudden or gradual, scalp symptoms, recent illnesses and your treatment list. Include the GLP-1 product and its start date without assuming it explains the whole pattern. Ask the clinician to name the condition being treated and the expected purpose of the proposed medicine.
Our topical-minoxidil diagnosis and label guide considers a different foam trial. It should not be treated as the same formulation comparison.
Agree on monitoring before a tablet prescription
Royal Berkshire NHS Foundation Trust's October 2025 patient leaflet describes specialist assessment before treatment and regular pulse and blood-pressure monitoring during oral minoxidil use. It advises against minoxidil when trying to conceive, pregnant or breastfeeding. This is U.K. service guidance; your prescriber should specify the plan for your product and circumstances.[3]
Ask who will arrange the checks, when the first review is due and how results reach the prescriber. Bring all medicines, supplements and nonprescription products. Request clear instructions if you already take a medicine affecting blood pressure or have experienced dizziness.
MedlinePlus describes oral minoxidil primarily as a blood-pressure medicine. It advises telling the prescriber about heart or kidney disease, pregnancy or breastfeeding, and all other medicines. It says to follow the prescription rather than taking more or changing it yourself.[4]
Know which symptoms need immediate advice
MedlinePlus advises calling your doctor immediately for new or worsening chest pain while taking oral minoxidil. Its serious-symptom list also includes fast heartbeat, swollen feet or ankles, unexplained weight gain, breathing difficulty, dizziness and fainting.[4]
Keep that contact information with your instructions. Severe symptoms or a medical emergency need emergency care. Do not wait for a planned hair-photo review to report them.
Before leaving the consultation, confirm the diagnosis, exact product, instructions, monitoring arrangement and review date. The hair-history guide can help organize the account you bring.
Printed book
How to Keep Your Face on GLP-1
$12.95 + free shipping
Order Now30 day money back guarantee
This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.
Read next
Hair & nailsBiotin on GLP-1: Hair, Nails and Blood-Test Questions→Hair & preparationBrow Tint During GLP-1: 5 Safety Checks→Sources
- Low-Dose Oral Versus Topical Minoxidil in Androgenetic Alopecia: A Randomized, Double-Blind, Double-Dummy Controlled TrialChaudhry and colleagues, Journal of Cosmetic Dermatology, September 2026↩ Back to text
- Hair loss: Diagnosis and treatmentAmerican Academy of Dermatology; updated December 2022, checked October 2026↩ Back to text
- Minoxidil for hair lossRoyal Berkshire NHS Foundation Trust, October 2025 patient leaflet; checked October 2026↩ Back to text
- Minoxidil: oral medicine informationMedlinePlus, U.S. National Library of Medicine; revised January 2018, checked October 2026↩ Back to text

